Saturday, February 25, 2017 11:26:06 AM
More than one important paper in empirical finance has demonstrated this effect. Stocks with lottery characteristics tend to be over-priced.
As pointed out by Bali, Cakici and Whitelaw in their much reference paper Maxing Out: Stocks as Lotteries and the Cross-Section of Expected Returns; investors tend to irrationally over value lottery-like speculations and assume the probability of success is higher than they in fact are. For this reason investors in such stocks experience relatively low risk-adjusted returns.
This may explain why option prices, that tend to be set by more sophisticated investors imply a price for NNVC that is considerably below the current market price.
This also explains why a Randy Mills can extract so much money from private investors for an idea that is provably wrong. As mentioned before, there is no way for Quantum Mechanics to be wrong, a central contention of Mills and for devices based on computer chips and lasers to works as flawlessly as they do. Every day in hundreds of ways the average person sees clear cut evidence that QM is right and Mills is wrong.
The only issue is this: Is Mills a crook or a crack-pot. The former knows it's snake oil, the latter does not.
Beware of the lottery-effect.
Trendliner
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM